期刊文献+

益赛普治疗强直性脊柱炎的护理 被引量:3

Nursing of patients with ankylosing spodylitis treated by the etanercept
下载PDF
导出
摘要 益赛普(重组人肿瘤坏死因子α受体-抗体融合蛋白)是一种生物制剂,在国内应用时间尚短,本文报告16例强直性脊柱炎患者应用益赛普治疗的护理。通过心理护理、功能锻炼、生活护理,主要观察用药后的副作用包括皮肤注射部位反应、皮疹和感染等一系列护理措施,达到较好的临床疗效。 tanercept (a recombinant human tumor necrosis factor a receptor - antibody fusion protein) is a biologic agent, It has been used for a very short time in our country. In this article we reported the nursing of 16 patients with ankylosing spodylitis who received the etanercept treatment. Side effects including skin reaction in injection area, rashes and infections were observed. We have achieved good clinical effect through mental nursing, functional exercise, life nursing, et al.
出处 《现代护理》 2007年第09Z期2470-2471,共2页 Modern Nursing
关键词 强直性脊柱炎 益赛普 护理 Ankylosing spodylitis Etanercept Nursing
  • 相关文献

参考文献3

二级参考文献18

  • 1Feldmann M, Brennan FM, Maini RN. The role of cytokines in rheumatoid arthritis. Ann Rev Immunol, 1996, 14: 397-440.
  • 2Wooley PH, Dutcher J, Widmer MB, et al. Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type Ⅱ collagen-induced arthritis in mice. J Immunol,1993, 151: 6602-6607.
  • 3Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum, 1995, 6: 727-735.
  • 4Felson DT, Anderson JJ, Boers M, et al. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum, 1995, 38:727-735.
  • 5American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum, 1996, 39: 713.
  • 6Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. New Engl J Med, 1994, 330: 1369-1375.
  • 7Firestein GS, Zvaifler NJ. Anticytokine therapy in rheumatoid arthritis. New Engl J Med, 1997, 337: 195-197.
  • 8Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of Etanercept and methotrexate in patients with early rheumatoid arthritis. New Eng J Med, 2000, 343: 1586-1593.
  • 9Moreland LW, Cohen SB, Baumgartner SW, et al. Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. J Rheumatol,2001, 28: 1238-1244.
  • 10Weinblatt ME, Kremer JM, Bankhurst A, et al. A trial of etanercept: a recombinant tumor necrosis factor receptor: Fc fusion protein in patients with rheumatoid arthritis receiving methotrexate.New Engl J Med, 1999, 340: 253-259.

共引文献107

同被引文献4

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部